Xylitol Adult Caries Trial (X-ACT)

PHASE3CompletedINTERVENTIONAL
Enrollment

709

Participants

Timeline

Start Date

January 31, 2007

Primary Completion Date

June 30, 2011

Study Completion Date

June 30, 2011

Conditions
Dental Caries
Interventions
DIETARY_SUPPLEMENT

xylitol

1g xylitol lozenges to be dissolved in mouth. Five lozenges daily for three years

DIETARY_SUPPLEMENT

inactive lozenge

1g inactive lozenge, dissolved in mouth. Five/day for three years

Trial Locations (3)

35294-0111

University of Alabama at Birmingham, Birmingham

27599-7450

University of North Carolina School of Dentistry, Chapel Hill

78229-3900

University of Texas Health Science Center, San Antonio

All Listed Sponsors
collaborator

National Institute of Dental and Craniofacial Research (NIDCR)

NIH

lead

University of North Carolina, Chapel Hill

OTHER

NCT00393055 - Xylitol Adult Caries Trial (X-ACT) | Biotech Hunter | Biotech Hunter